High-temperature colorants that can withstand sterilization to 150°C and up to 1,000 autoclave cycles

If carrier's driver is not able or is not given an opportunity to inspectand count the shipment prior to acceptance by the carrier, the bill of lading must be noted "SL & C" (Shippers Load & Count).

All Rights Reserved 2024 34 Plastic lightweighting CATALYZE THE CORE M ARKET DRIVERS & NEEDS • Reducing material and energy usage • Achieving sustainability goals and objectives • Improved product performance, structural integrity $5B ADDRESSABLE MARKET A V I E N T E N D M A R K E T S , A P P L I C A T I O N S AVIENT VALUE PROPOSITION • Best-in-class additives for a wide range of polymer processing temperatures • Design services to simulate foaming and mold designs TransportationWood plasticcomposite decking Bottles and food packaging Building and construction Copyright © . • New growth opportunities in prefabricated / modular construction - driven by lightweighting, waste reduction, and energy efficiency • Avient differentiation is with operational velocity, manufacturing capability and added functionality with flame retardancy vital to this space $20B ADDRESSABLE MARKET A V I E N T T E C H N O L O G I E S , S O L U T I O N S Ballistic-resistant panels Composite lumber reinforcement Functional panels - interiors and exteriors Fire-retardant thermoplastic panels Copyright © . $8B ADDRESSABLE MARKET A V I E N T T E C H N O L O G I E S , S O L U T I O N S Cross arms Turbine blade stiffeners Utility poles Insulator rods Copyright © .

Microsoft PowerPoint - AVNT Q3 2022 Earnings Presentation AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 2 R E S U L T S (NYSE: AVNT) N O V E M B E R 2 , 2 0 2 2 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EBITDA Margins (1) • Focus on organic growth combined with transformative and bolt-on acquisitions • Divested commodity businesses tied to more cyclical end markets • Expanded presence in high growth areas of sustainable solutions, specialty healthcare applications, composites and more resilient end markets 5.4% 11.5% 16.1% 2006 2018 2022PF $142 $408 $585 2006 2018 2022PF 2006 figures exclude joint venture results 14 RETURNING CASH TO SHAREHOLDERS Growing Dividend 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 22 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 0.99 11 12 13 14 15 16 17 18 19 20 21 22 23 ~$1Bn REPURCHASED OVER LAST 11 YEARS ~$550MM PAID OVER LAST 11 YEARS Dividends Share Repurchases Cumulative Buybacks $ B n $ p e r sh a re $2.95 2022 PRO FORMA ADJUSTED EPS Earnings Growth Expanding Profitability $0.15 $1.09 $2.08 $2.67 $2.95 2009 2012 2015 2018 2022PF T H I R D Q U A R T E R 2 0 2 2 R E S U L T S $110 $119 2021 2022 $0.61 $0.59 2021 2022 Q3 2022 PERFORMANCE ( T O TA L C O M PA N Y C O N T. O P S ) 16 Sales Adjusted EBITDA $818 $823 2021 2022 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 17 Price increases more than offset raw material and supply chain impacts $ millions CAI: Price / Mix 68 Inflation (44) SEM: Price / Mix 41 Inflation (26) Net Price Benefit 39 Wage and Energy Inflation (14) Clariant Color Integration Synergies 6 Incentives, Other Employee Costs 14 FX (11) Q3 2022 $137   Adjusted EBITDA Q3 2021 $ 142 Demand (39) Q3 2022 SEGMENT PERFORMANCE 18 CAI $587 $566 Sales ($ in millions) $93 $93 EBITDA SEM Pro Forma $326 $319 Sales $70 $62 EBITDA (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 Cont.

Polymer Diagnostics Inc. 33587 Walker Road Avon Lake, Ohio 44012 United States +1 800 438 2335 +1 440 930 1644 fax Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities. 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810 Polymer Diagnostics Inc. PDI has extensive experience with the testing of medical devices and materials including: • Catheters • Bio-implants • Surgical diagnostic devices • Medical tubing • Other disposable medical devices Issues often arise as a result of: • Improper design or choice of material • The environment of exposure • Processing conditions World-class people and capabilities under one roof • Failure Analysis/Prevention • Qualifi cation Support • Rheology • Polymer Characterization • Deformulation • Physical Testing • Litigation Support • Characterization of polymers in pharmaceutical delivery systems • Phthalate and BPA testing 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810 Polymer Diagnostics Inc. Polymer Diagnostics Inc. 33587 Walker Road Avon Lake, Ohio 44012 United States +1 800 438 2335 +1 440 930 1644 fax Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the American Association for Laboratory Accreditation (A2LA) for both chemical and mechanical capacities. 1 7 . 2 8 . 2 5 i n 8 . 5 i n 1 7 C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810 TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM BL: 17.2500" x 11.9375" FINAL: 8.2500" x 11.6875" and 8.500" x 11.000" 11 .6 8 7 5 in 2 5 i n 11 .9 3 7 5 in 8 . 2 5 i n 8 . 5 i n 11 in i n Asset No. 78810

Images of A) Trilliant HC8900 series, B) FR PC alloys, and C) FR copolyester tensile bars in the strain apparatus following a 72-hour treatment with Virex® TB. R.; Richards, C. C.; Gaynes, R.

% Pigment Specific Gravity Color Index Lightfastness WHITE 10EPX03 Titanium Dioxide, Rutile 57 1.95 PW-6 I/O YELLOW 12EPX01 Diarylide AAOT GS 25 1.22 PY-14 I 12EPX03 Diarylide HR RS 20 1.2 PY-83 I/O (Mass) 13EPX02 Isoindolinone RS 30 1.3 PY-110 I/O 13EPX03 Benzimidazolone GS 40 1.27 PY-151 I/O (Mass) 81EPX01 Iron Oxide 40 1.62 PY-42 I/O ORANGE 15EPX03 Benzimidazolone 30 1.26 PO-36 I/O RED 23EPX04 Quinacridone BS 25 1.21 PV-19 I/O 23EPX06 Specialty Naphthol BS 30 1.21 PR-170 I/O (Mass) C 25EPX01 Red 2B, Ca Salt Bs 24 1.27 PR-48:2 I/O (Mass) 28EPX01 Red 2B, Ba Salt YS 23 1.29 PR-48:1 I/O (Mass) 82EPX01 Iron Oxide, Light BS 40 1.67 PR-101 I/O 82EPX02 Iron Oxide, Dark BVS 40 1.68 PR-101 I/O 82EPX04 Iron Oxide, Light VYS 40 1.67 PR-101 I/O BLUE 40EXP03 Phthalocyanine GS 25 1.25 PB-15:3 I/O 40EXP05 Phthalocyanine RS 25 1.25 PB-15:3 I/O 42EXP02 Ultramarine 50 1.54 PB-29 I/O 49EXP01 Cobalt 50 1.83 PB-28 I/O GREEN 50EPX02 Phthalocyanine BS 18 1.34 PG-7 I/O 50EPX03 Phthalocyanine YS 25 1.42 PG-7 I/O 59EPX01 Chromium Oxide 40 1.64 PG-17 I/O VIOLET/MAGENTA 24EPX03 Quinacridone Violet 15 1.2 PV-19 I/O 24EPX04 Ultramarine Violet 50 1.66 PV-15 I/O 24EPX05 Quinacridone Magenta 20 1.21 PR-122 I/O 24EPX06 Benzimidazolone 20 1.2 PV-32 I/O 24EPX07 Carbazole Violet 15 1.2 PV-23 I/O BROWN/TAN 83EPX01 Iron Oxide, Light 39 1.64 PBr-6 I/O 83EPX02 Iron Oxide, Dark 40 1.66 PBr-6 I/O BLACK 90EPX01 Furnace - High Jet 14 1.23 PBk-7 I/O 90EPX04 Furnace - Medium 20 1.25 PBk-7 I/O 90EPX05 Iron Oxide 50 1.77 PBk-11 I/O EPX RS = Red Shade YS = Yellow Shade VYS = Very Yellow Shade BS = Blue Shade VBS = Very Blue Shade GS = Green Shade HR = Heat-Resistant LIGHTFASTNESS I = Indoor Only I/O = Indoor or Outdoor Mass = Outdoor Masstone Application Only C = Some Caution Advised www.avient.com Copyright © 2020, Avient Corporation.

Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E •• •• •• JVs Performance Products & Solutions Distribution Specialty     To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results.

DOCUMENT NUMBER_ SSS-003 CATEGORY DETAIL EC Number 215-175-0 CAS Number 1309-64-4 Name Subclass 1 Antimony Trioxide (ATO) Structural Formula CHEMICAL IDENTITY PROPERTY DETAIL Physical State Solid Form Powder Color White Odor Odorless Melting Point 656°C Boiling Point 1425°C Bulk Density 5.20 g/cm3 Water Solubility Slightly Soluble PHYSICAL/ CHEMICAL PROPERTIES DOCUMENT NUMBER_ SSS-003 HEALTH EFFECTS HUMAN HEALTH SAFETY ASSESSMENT Consumer It is very unlikely that consumers would be exposed to ATO in its concentrated form because it is only sold for industrial use to make polymers and other products and is not sold directly to consumers.

Mulch films case study BIODEGRADABLE & COMPOSTABLE M U L C H F I L M S • Compliance with European Standard EN17033 or OK Compost • Black and white color standards available under different TÜV Austria certifications (OK Compost and more) • Full support for end-product certification for both EN13432 and EN17033 • Formulated with pigments tested and approved by certified body OnColor™ Bio-Colorants KEY REQUIREMENTS WHY AVIENT?